(Q45365669)

13 December 2017

title

Health utilities and psychometric quality of life in patients with early- and late-stage hepatitis C virus infection (English)

1 reference

13 December 2017

1 reference

1 reference

1 reference

8

1 reference

13 December 2017

3

Mel Krajden

1 reference

13 December 2017

2

Carole A Federico

1 reference

13 December 2017

1

Priscilla C Hsu

1 reference

13 December 2017

Eric M Yoshida

4

1 reference

13 December 2017

Karen E Bremner

series ordinal

5

1 reference

13 December 2017

Frank H Anderson

series ordinal

6

1 reference

13 December 2017

Alan A Weiss

series ordinal

7

1 reference

13 December 2017

publication date

1 January 2012

1 reference

Journal of Gastroenterology and Hepatology

13 December 2017

published in

1 reference

13 December 2017

volume

27

1 reference

13 December 2017

issue

1

1 reference

13 December 2017

page(s)

149-157

1 reference

Management of hepatitis C-infected liver transplant recipients at large North American centres: changes in recent years

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

Management of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

Outcome of sustained virological responders with histologically advanced chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

US norms for six generic health-related quality-of-life indexes from the National Health Measurement study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

Comorbidities and quality of life in patients with interferon-refractory chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

Assessment of utilities and health-related quality of life in patients with chronic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

Does cirrhosis affect quality of life in hepatitis C virus-infected patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

Validity of the Telephone Interview for Cognitive Status (TICS) in post-stroke subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

Assessment of cognitive status in the elderly using telephone interviews.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

Multi-attribute preference functions. Health Utilities Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

Utility approach to measuring health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

Health values of patients with chronic hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

The estimation of a preference-based measure of health from the SF-36.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

The Importance of Co-existent Disease in the Occurrence of Postoperative Complications and One-Year Recovery in Patients Undergoing Total Hip Replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

The Health Utilities Index (HUI): concepts, measurement properties and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

Utility scores for chronic conditions in a community-dwelling population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

Prognosis of hepatocellular carcinoma: the BCLC staging classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

Host- rather than virus-related factors reduce health-related quality of life in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

Drug addiction in hepatitis C patients leads to a lower quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

The impact of chronic hepatitis B on quality of life: a multinational study of utilities from infected and uninfected persons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

Health-state utilities in a prisoner population: a cross-sectional survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

Health-State Utilities and Quality of Life in Hepatitis C Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06813.X

10.1111/J.1440-1746.2011.06813.X

21 January 2018

Identifiers

DOI

1 reference

13 December 2017

1 reference